abiraterone has been researched along with Nausea in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moore, A; Moore, DC | 1 |
Chieffo, N; Efstathiou, E; Hoang, A; Karlou, M; Logothetis, CJ; Molina, A; Smith, LA; Titus, M; Troncoso, P; Tsavachidou, D; Tzelepi, V; Wen, S | 1 |
1 trial(s) available for abiraterone and Nausea
Article | Year |
---|---|
Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone.
Topics: Adult; Aged; Aged, 80 and over; Androstenes; Androstenols; Bone Marrow; Bone Neoplasms; Castration; Disease-Free Survival; Drug Administration Schedule; Fatigue; Histone Deacetylase Inhibitors; Humans; Infections; Infusions, Intravenous; Male; Middle Aged; Nausea; Prostatic Neoplasms; Receptors, Androgen; Remission Induction; Testosterone; Vascular Diseases; Young Adult | 2012 |
1 other study(ies) available for abiraterone and Nausea
Article | Year |
---|---|
Abiraterone-induced rhabdomyolysis: A case report.
Topics: Analgesics, Opioid; Androstenes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Constipation; Creatine Kinase; Cytochrome P450 Family 17; Drug Therapy, Combination; Humans; Injections, Spinal; Male; Middle Aged; Morphine; Nausea; Pain Management; Prednisone; Prostatic Neoplasms, Castration-Resistant; Rhabdomyolysis; Vomiting | 2017 |